• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,658.24 149.83
(0.29%)
Dow Jones
7,594.79 30.15
(0.40%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Bal Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524824
INE083D01012
65.3864135
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BALPHARMA
18.79
126.86
EPS(TTM)
Face Value()
Div & Yield %
4.24
10
1.51
 

cella space ltd
Genesys International Corporation consolidated net profit declines 34.78% in the March 2026 quarter
Jun 01,2026
Net profit of Genesys International Corporation declined 34.78% to Rs 12.36 crore in the quarter ended March 2026 as against Rs 18.95 crore during the previous quarter ended March 2025. Sales rose 10.68% to Rs 104.22 crore in the quarter ended March 2026 as against Rs 94.16 crore during the previous quarter ended March 2025.

For the full year,net profit declined 42.05% to Rs 32.58 crore in the year ended March 2026 as against Rs 56.22 crore during the previous year ended March 2025. Sales rose 5.39% to Rs 327.81 crore in the year ended March 2026 as against Rs 311.03 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales104.2294.16 11 327.81311.03 5
OPM %32.7252.86 -33.3645.69 -
PBDT34.2046.80 -27 116.57137.70 -15
PBT17.0931.52 -46 51.5982.68 -38
NP12.3618.95 -35 32.5856.22 -42